Загрузка страницы

What is the outlook for AML-MRC, tAML, and secondary AML?

Learn more about AML at http://www.YouAndAML.com
Acute myeloid leukemia expert Dr. Sandra Kurtin explains that the outlook for people with acute myeloid leukemia with myelodysplasia-related changes (AML-MRC), treatment-related AML (tAML) or secondary myelodysplastic syndrome (secondary MDS) is usually less good than for de novo AML. People who can have a stem cell transplant, also called a bone marrow transplant, have a better outlook with these secondary types of AML. Clinical trials of new treatments may also improve the outlook for AML-MRC, tAML and secondary AML.

Видео What is the outlook for AML-MRC, tAML, and secondary AML? канала You and AML
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
28 ноября 2019 г. 3:32:44
00:01:11
Яндекс.Метрика